![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 471/08 | (2006.01) |
A61K 31/439 | (2006.01) | ||
A61P 31/04 | (2006.01) |
(11) | Number of the document | 3221313 |
(13) | Kind of document | T |
(96) | European patent application number | 15801091.8 |
Date of filing the European patent application | 2015-11-17 | |
(97) | Date of publication of the European application | 2017-09-27 |
(45) | Date of publication and mention of the grant of the patent | 2019-01-09 |
(46) | Date of publication of the claims translation | 2019-03-25 |
(86) | Number | PCT/US2015/061076 |
Date | 2015-11-17 |
(87) | Number | WO 2016/081452 |
Date | 2016-05-26 |
(30) | Number | Date | Country code |
201462080667 P | 2014-11-17 | US |
(72) |
DEJONGE, Boudewijn, Lodewijk Maria, US
DURAND-REVILLE, Thomas, Francois, US
VERHEIJEN, Jeroen, Cunera, US
TOMMASI, Ruben, US
MUELLER, John, US
|
(73) |
Entasis Therapeutics Limited,
2 Kingdom Street, London W2 6BD,
GB
|
(74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
(54) | Derinių terapija, skirta atsparių bakterinių infekcijų gydymui |
COMBINATION THERAPY FOR TREATMENT OF RESISTANT BACTERIAL INFECTIONS |
Payment date | Validity (years) | Amount | |
2024-10-31 | 10 | 231.00 EUR |
2025-11-17 |